Name Surname

• Designed and developed multiplex PCA (pulse-controlled amplification) assays in an ISO 13485 certified environment. • Managed project planning and timelines; trained team members and mentored their professional development. • Led cross-site (Europe & the US) communications for assay development and collaborated with other teams to build an integrated system. • Supported system integration by troubleshooting and providing expert advice on experimental design, risk identification, and data quality.

• Developed cyberPCR assays to detect oncological mutations in human gDNA. • Upgraded the 3-step assay to a 2-step assay, enabling real-time detection

• Led the Rutgers team to develop the Xpert MTB/XDR assay (CE-IVD marked) in collaboration with Cepheid Inc.. • Created, validated, and published an R algorithm for identification of rpoB RRDR mutations using Xpert MTB/RIF Ultra results. • Designed a novel PCR method to amplify overlapping amplicons in a single tube. • Developed an algorithm in Excel for a new melting curve analysis method for Cepheid SW team. • Worked on the DIR study for Xpert MTB/RIF Ultra assay.

• Developed a helicase-dependent amplification (HDA) assay for real-time TB detection; • Evaluated assay on over 500 clinical samples and compared with smear, culture and PCR methods; improved assay against inhibition in sputum samples (China patent issued); • Optimised assay for lyophilisation; performed functional and stability study of dried reagent mix; • Developed QC assays for enzyme activity test, and tested locally produced enzymes; • Assisted in evaluating a new sample preparation method.